RecallRadar

FDA Drug recall D-0447-2026

GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC…

On 2026-04-15 the FDA classified a Class II recall of GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC… by Ge Healthcare Ireland, citing presence of particulate matter.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0447-2026
ClassificationClass II
Statusongoing
Initiated2026-03-24
Published2026-04-15
Last updated2026-09-13 11:52 UTC
CompanyGe Healthcare Ireland
DistributionUS

Product

GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1413-63.

Reason

Presence of particulate matter

Identifiers

ndc0407-1401-52
ndc0407-1411-10
ndc0407-1411-20
ndc0407-1412-10
ndc0407-1412-20
ndc0407-1412-50
ndc0407-1412-29
ndc0407-1412-30
ndc0407-1412-60
ndc0407-1412-33
ndc0407-1412-27
ndc0407-1412-49
ndc0407-1412-34
ndc0407-1412-28
ndc0407-1412-35
ndc0407-1413-11
ndc0407-1413-10
ndc0407-1413-59
ndc0407-1413-30
ndc0407-1413-50
ndc0407-1413-51
ndc0407-1413-61
ndc0407-1413-95
ndc0407-1413-98
ndc0407-1413-62
ndc0407-1413-99
ndc0407-1413-60
ndc0407-1413-63
ndc0407-1413-91
ndc0407-1413-53
ndc0407-1413-90
ndc0407-1413-65
ndc0407-1413-92
ndc0407-1413-66
ndc0407-1413-93
ndc0407-1413-96
ndc0407-1413-69
ndc0407-1414-21
ndc0407-1414-50
ndc0407-1414-51
ndc0407-1414-52
ndc0407-1414-89
ndc0407-1414-20
ndc0407-1414-90
ndc0407-1414-22
ndc0407-1414-53
ndc0407-1414-60
ndc0407-1414-91
ndc0407-1414-76
ndc0407-1414-03
ndc0407-1414-23
ndc0407-1414-93
ndc0407-1414-04
ndc0407-1414-94
ndc0407-1414-24
ndc0407-1414-80
ndc0407-1414-95
ndc0407-1415-09
ndc0407-1416-12
code_info
Lot# 17225029; Exp. September 3, 2028 Lot# 17265376; Exp. October 3, 2028 Lot# 17270885; Exp. September 10, 2028 Lot# 1…Lot# 17225029; Exp. September 3, 2028 Lot# 17265376; Exp. October 3, 2028 Lot# 17270885; Exp. September 10, 2028 Lot# 17292246; Exp. October 4, 2028 Lot# 17301805; Exp. October 18, 2028 Lot# 17301807; Exp. September 7, 2028 Lot# 17301810; Exp. October 20, 2028 Lot# 17304992; Exp. October 5, 2028 Lot# 17304993; Exp. October 19, 2028 Lot# 17304996; Exp. November 25, 2028 Lot# 17321225; Exp. September 8, 2028 Lot# 17333589; Exp. November 24, 2028 Lot# 17333611; Exp. November 26. 2028 Lot# 17333613; Exp. November 23. 2028 Lot# 17357000; Exp. December 5, 2028 Lot# 17366399; Exp. December 14, 2028 Lot# 17376486; Exp. December 14, 2028 Lot# 17404114; Exp. December 6, 2028

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0447-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.